As therapies for HIV have advanced to help many patients control the infection as a chronic disease, investigators and patients have set their sights on a new goal: finding a cure. Drs. Douglas Nixon and Brad Jones have recently joined Weill Cornell Medicine in the hopes of accelerating that hunt.
Researchers in the lab of Charles Danko have developed a new tool to study genetic “switches” active in glioblastoma tumors that drive growth of the cancer.
C. Richard Johnson will speak about the field of computational art history and discuss preserving and authenticating the works of Vermeer and Rembrandt Nov. 9.
Experts will discuss the role of energy startups, new investment strategies and the impact investing will play in shaping the future of the energy industry Nov. 2.
President Martha E. Pollack updated the Cornell community Oct. 16 on the work of a faculty visioning committee asked to generate ideas that will enhance the university's presence in New York City.
The seventh Cornell Entrepreneurship Summit NYC will be held in Manhattan Nov. 9 and will feature talks from the founders of the Pink Ceiling and Bluemercury.
Ultrasmall Cornell dots armed with antibodies are another weapon in the fight against cancer, says Uli Wiesner, professor of materials science and engineering.
